Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases ...

After downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as ...

Astellas Pharma, BridgeBio, BeOne Medicines and six other large biotechs join the 17 Big Pharmas that previously signed on to ...

Novartis suspended multiple studies of a CAR T candidate after three patients who received the therapy suffered fatal cases ...

Biomarin has granted Ascendis a non-exclusive, worldwide license to use navepegritide, the active ingredient in the latter ...

The U.S. is scrambling to compete with a strategically positioned China on the biotech stage as the Asian country surpasses ...

Well-known for its oncology efforts and making recent headlines for a rumored mega merger with AstraZeneca, Bristol Myers ...

Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would ...

AstraZeneca and Ionis Pharmaceuticals’ data drop divulging more details from its highly watched Phase 3 transthyretin ...

Teva Pharmaceuticals is the 'stalking horse bidder' to kick off the auction process for BioXcel Therapeutics' AI-derived ...

With the approval, Eli Lilly’s Mounjaro becomes the first dual GIP/GLP-1 receptor agonist indicated to lower the risk of ...